| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,640,449 | 2,466,970 | 2,458,861 | | Cost of Revenue | 1,379,207 | 2,145,519 | 2,073,117 | | | Gross Profit | 261,242 | 321,451 | 385,744 | | | Operating Expenses | | Research Development | 143,291 | 168,275 | 182,869 | | Selling General and Administrative | 257,559 | 319,145 | 334,455 | | Non Recurring | 32,497 | 30,115 | (12,291) | | Others | 4,111 | 15,961 | 18,871 | | | | Total Operating Expenses | 437,458 | 533,496 | 523,904 | | | | Operating Income or Loss | (176,216) | (212,045) | (138,160) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 42,918 | 79,256 | 15,921 | | Earnings Before Interest And Taxes | (133,298) | (132,789) | (122,239) | | Interest Expense | 10,439 | 32,676 | 11,688 | | Income Before Tax | (143,737) | (165,465) | (133,927) | | Income Tax Expense | 7,087 | 32,898 | (15,024) | | Minority Interest | 508 | 2,788 | 1,558 | | | | Net Income From Continuing Ops | (150,316) | (195,575) | (117,345) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (150,316) | (195,575) | (117,345) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($150,316) | ($195,575) | ($117,345) |
|
1.48% Nasdaq 
Income Statement
